Michael Vogelbaum

Title: Michael Vogelbaum and a Combination-Therapy Patent

Introduction

Michael Vogelbaum is an inventor associated with Tampa, Florida, and the biotechnology company MediciNova, Inc. His patent work concerns a proposed combination therapy for glioblastoma multiforme, an aggressive form of brain cancer.

Latest Patents

Vogelbaum is associated with 1 patent: “Methods of Treating Glioblastoma Multiforme Using Combination Therapy.” The patent describes compositions and methods for treating glioblastoma through administration of ibudilast, also known as 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine, or a pharmaceutically acceptable salt of the compound, together with an immune checkpoint inhibitor.

Career Highlights

The disclosed invention focuses on combining a drug with an immune checkpoint inhibitor as a potential approach to glioblastoma treatment. The patent description identifies the proposed treatment method but does not, by itself, establish its clinical effectiveness or regulatory approval.

Collaborations

Vogelbaum’s listed coworkers include Kazuko Matsuda and Justin Lathia. Their inclusion indicates professional connections, though the provided information does not specify their roles in this patent.

Conclusion

Michael Vogelbaum’s patent activity centers on a proposed ibudilast and immune checkpoint inhibitor combination for glioblastoma, reflecting an effort to explore combination-based approaches to cancer treatment.